|
ZNF555 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.82979981061737E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18190002229568E-09 |
| Normal-vs-Stage2 |
7.99740000001492E-07 |
| Normal-vs-Stage3 |
5.53790346913274E-11 |
| Normal-vs-Stage4 |
3.59799967597496E-10 |
| Stage1-vs-Stage2 |
3.454400E-01 |
| Stage1-vs-Stage3 |
7.161900E-02 |
| Stage1-vs-Stage4 |
1.703170E-01 |
| Stage2-vs-Stage3 |
5.517800E-02 |
| Stage2-vs-Stage4 |
9.127700E-02 |
| Stage3-vs-Stage4 |
9.848600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52480028603463E-10 |
| Normal-vs-AfricanAmerican |
1.53355999999993E-05 |
| Normal-vs-Asian |
2.23789999997948E-06 |
| Caucasian-vs-AfricanAmerican |
9.567200E-01 |
| Caucasian-vs-Asian |
4.903900E-02 |
| AfricanAmerican-vs-Asian |
2.656000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.61159996459048E-09 |
| Normal-vs-Female |
3.53770013283849E-10 |
| Male-vs-Female |
7.358800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.69729996724044E-09 |
| Normal-vs-Age(41-60Yrs) |
1.86309967453724E-10 |
| Normal-vs-Age(61-80Yrs) |
3.08339997978635E-09 |
| Normal-vs-Age(81-100Yrs) |
7.797300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.175000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.599800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.873800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.159400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.389800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.348800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.282100E-03 |
| Classical-VS-Follicular |
2.154000E-01 |
| Classical-VS-Other |
7.364200E-01 |
| Classical-VS-Normal |
1.39650002672909E-09 |
| Tall-VS-Follicular |
7.638200E-04 |
| Tall-VS-Other |
2.771600E-01 |
| Tall-VS-Normal |
4.58866278307823E-12 |
| Follicular-VS-Other |
5.290000E-01 |
| Follicular-VS-Normal |
6.9243999978319E-08 |
| Other-VS-Normal |
5.515200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.86650003522971E-09 |
| Normal-vs-N1 |
1.11669562485872E-11 |
| N0-vs-N1 |
5.257000E-03 |
|
|
